1. Home
  2. BRID vs ANL Comparison

BRID vs ANL Comparison

Compare BRID & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRID
  • ANL
  • Stock Information
  • Founded
  • BRID 1932
  • ANL 2004
  • Country
  • BRID United States
  • ANL Cayman Islands
  • Employees
  • BRID N/A
  • ANL N/A
  • Industry
  • BRID Specialty Foods
  • ANL
  • Sector
  • BRID Consumer Staples
  • ANL
  • Exchange
  • BRID Nasdaq
  • ANL Nasdaq
  • Market Cap
  • BRID 72.6M
  • ANL 73.8M
  • IPO Year
  • BRID N/A
  • ANL 2023
  • Fundamental
  • Price
  • BRID $7.94
  • ANL $1.84
  • Analyst Decision
  • BRID
  • ANL Strong Buy
  • Analyst Count
  • BRID 0
  • ANL 2
  • Target Price
  • BRID N/A
  • ANL $9.00
  • AVG Volume (30 Days)
  • BRID 3.3K
  • ANL 30.5K
  • Earning Date
  • BRID 05-30-2025
  • ANL 05-13-2025
  • Dividend Yield
  • BRID N/A
  • ANL N/A
  • EPS Growth
  • BRID N/A
  • ANL N/A
  • EPS
  • BRID N/A
  • ANL N/A
  • Revenue
  • BRID $221,348,000.00
  • ANL N/A
  • Revenue This Year
  • BRID N/A
  • ANL N/A
  • Revenue Next Year
  • BRID N/A
  • ANL N/A
  • P/E Ratio
  • BRID N/A
  • ANL N/A
  • Revenue Growth
  • BRID N/A
  • ANL N/A
  • 52 Week Low
  • BRID $7.52
  • ANL $1.26
  • 52 Week High
  • BRID $14.69
  • ANL $13.92
  • Technical
  • Relative Strength Index (RSI)
  • BRID 41.03
  • ANL 43.67
  • Support Level
  • BRID $7.82
  • ANL $1.10
  • Resistance Level
  • BRID $8.37
  • ANL $2.10
  • Average True Range (ATR)
  • BRID 0.22
  • ANL 0.19
  • MACD
  • BRID 0.05
  • ANL 0.00
  • Stochastic Oscillator
  • BRID 46.67
  • ANL 67.27

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: